We are live on
!
Find out more
LSB
LakeShore Biopharma
Delisted
LSB was delisted on the 19th of September, 2025.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
1
Barclays
London,
United Kingdom
| $18.1K | – | – | – |
|
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
| – | -$119K | -116,508 | Closed |
|
| 3 |
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
| – | -$76.7K | -75,179 | Closed |
|
| 4 |
O
4
OrbiMed
New York
| – | -$55.9K | -54,799 | Closed |
|
| 5 |
SCM
5
Superstring Capital Management
New York
| – | -$31.4K | -30,792 | Closed |
|
| 6 |
6
Citadel Advisors
Miami,
Florida
| – | -$15.3K | -14,963 | Closed |
|
| 7 |
7
UBS Group
Zurich,
Switzerland
| – | -$6.6K | -6,469 | Closed |
|